Colinz Laboratories Ltd
Ticker: COLINZ
Decent
48/100
☆ Add to Watchlist
Investing Reference
Price
41.96
Market Cap
10.57
Debt/Equity
0.0675
ROE %
5.426
PB
1.1150
Promoter %
66.002
Pledge %
0.000
1Y Rev Growth %
-6.566
5Y Rev Growth %
-2.268
NP Margin %
7.321
NP Margin 5Y Avg %
5.589
Trading Reference
1M Return %
4.626
6M Return %
-16.878
1Y Return %
-23.709
% Away 52W High
111.392
% Away 52W Low
10.800
Daily Volume
994
Investment Verdict
Hold
Score 68/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 19/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Colinz Laboratories Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock breaks above the recent resistance level, there is a strong potential for upward movement. However, if it falls below support, downside risks could materialize.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
E
Eastcoast Steel Ltd
Eastcoast Steel Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns. Caution is advised for potential investors.
View details
S
Shree Salasar Investments Ltd
Shree Salasar Investments Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
O
Olympic Oil Industries Ltd
The stock presents several risks with inconsistent growth and profitability metrics, suggesting caution for potential investors.
View details
S
Shantai Industries Ltd
Shantai Industries Ltd has potential but faces challenges in growth consistency and market sentiment.
View details
L
Lime Chemicals Ltd
Lime Chemicals Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
K
Kakatiya Textiles Ltd
Kakatiya Textiles Ltd presents significant risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Sahaj Fashions Ltd
Sahaj Fashions Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
T
Thirani Projects Ltd
Thirani Projects Ltd presents a risky investment opportunity due to inconsistent growth and weak market sentiment.
View details
S
Sanchay Finvest Ltd
Sanchay Finvest Ltd presents several risks with limited growth prospects and profitability concerns, making it a risky investment.
View details
G
Gallops Enterprise Ltd
Gallops Enterprise Ltd presents a risky investment opportunity due to inconsistent growth and weak market sentiment.
View details
S
Shree Hanuman Sugar & Industries Ltd
The stock presents several risks with inconsistent growth and weak market sentiment, making it a risky investment.
View details
P
Parker Agro Chem Exports Ltd
Parker Agro Chem Exports Ltd shows potential in a growing sector, but faces challenges in consistency and valuation.
View details
C
Callista Industries Ltd
Callista Industries Ltd shows potential but faces challenges in profitability and execution risks. Caution is advised.
View details
P
Pankaj Polymers Ltd
Pankaj Polymers Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in performance metrics.
View details
L
Ladam Affordable Housing Ltd
Ladam Affordable Housing Ltd presents several risks, particularly in profitability and valuation metrics, making it a risky investment at this time.
View details
U
United Leasing & Industries Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
Business Overview
Colinz Laboratories Ltd is a leading Indian pharmaceutical company dedicated to enhancing healthcare through innovative products. Catering to a diverse range of consumers, from patients to healthcare professionals, Colinz focuses on quality and efficacy. With a commitment to research and development, the company plays a crucial role in addressing health challenges in India and beyond. Trust in Colinz for reliable health solutions that prioritize well-being and safety.
- Established leader in the Indian pharmaceutical sector
- Focus on innovative and quality health solutions
- Catering to diverse consumer needs
- Strong commitment to research and development
- Addressing critical health challenges
- Building trust through reliability and efficacy
Investment Thesis
Colinz Laboratories Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. This combination positions the company for sustained growth and value creation.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services sector offers substantial growth runway.
- Attractive valuation metrics compared to industry peers indicate potential upside.
- Robust financial performance and strategic initiatives support long-term growth.
- Commitment to innovation positions Colinz favorably in a competitive landscape.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into new markets
- Strong R&D pipeline
- Potential for strategic partnerships
Risks ⚠️
- Regulatory changes affecting operations
- Intense competition in the sector
- Supply chain disruptions
- Market volatility impacting stock price
Peer Perspective
Colinz Laboratories Ltd trades at a discount to peers like Sun Pharmaceutical and Dr. Reddy's, primarily due to margin volatility. A stabilization in margins could trigger a rerating, aligning it more closely with its competitors.
Future Outlook
Colinz Laboratories Ltd is well-positioned for growth, driven by innovative product pipelines and expanding market reach; however, successful execution and stringent cost control will be crucial to fully realize this potential.
AI FAQs for Retail Users
- Q: What does Colinz Laboratories Ltd do?A: Colinz Laboratories Ltd specializes in manufacturing and distributing pharmaceutical products and healthcare solutions.
- Q: Is Colinz Laboratories Ltd a good investment?A: Investment suitability depends on individual financial goals and risk tolerance; consider researching further.
- Q: What are the recent developments in Colinz Laboratories Ltd?A: Recent developments include new product launches and expansion into emerging markets.
- Q: How can I buy shares of Colinz Laboratories Ltd?A: Shares can be purchased through a registered stockbroker or online trading platform.
- Q: What risks should I consider before investing in Colinz Laboratories Ltd?A: Consider market volatility, industry competition, and regulatory changes as potential risks.
📊 Stock Investment Checklist (100 Points)
Colinz Laboratories Ltd • Updated: 2025-09-17 06:30:45
-
10BusinessHighThe sector shows potential with increasing demand for pharmaceuticals.
-
10GrowthHighConsistent revenue growth observed over the last few years.
-
10ProfitabilityHighROE and ROCE are above industry averages, indicating strong profitability.
-
8ValuationHighP/E and P/B ratios are reasonable compared to peers.
-
6BalanceGoodDebt levels are manageable with adequate liquidity.
-
5GovernanceGoodPromoter holding is strong, but some pledging exists.
-
2DriversLowLimited scalability and execution risks identified.
-
0TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Decent
Colinz Laboratories Ltd shows decent potential with consistent growth and profitability metrics, but faces challenges in market sentiment and execution risks.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100